593 related articles for article (PubMed ID: 18098130)
1. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
3. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
5. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
7. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
10. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.
Wieland A; Riedl P; Reimann J; Schirmbeck R
Vaccine; 2009 Dec; 28(1):114-9. PubMed ID: 19818719
[TBL] [Abstract][Full Text] [Related]
11. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
12. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
[TBL] [Abstract][Full Text] [Related]
13. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
14. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
Mancini M; Hadchouel M; Tiollais P; Michel ML
J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
[TBL] [Abstract][Full Text] [Related]
15. Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.
Schirmbeck R; Dikopoulos N; Kwissa M; Leithäuser F; Lamberth K; Buus S; Melber K; Reimann J
Eur J Immunol; 2003 Dec; 33(12):3342-52. PubMed ID: 14635042
[TBL] [Abstract][Full Text] [Related]
16. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
Wu L; He JW; Yao X; Li HM; Wen YM
J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence.
Fissolo N; Riedl P; Reimann J; Schirmbeck R
Eur J Immunol; 2005 Jan; 35(1):117-27. PubMed ID: 15593127
[TBL] [Abstract][Full Text] [Related]
18. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.
Le Borgne S; Mancini M; Le Grand R; Schleef M; Dormont D; Tiollais P; Rivière Y; Michel ML
Virology; 1998 Jan; 240(2):304-15. PubMed ID: 9454704
[TBL] [Abstract][Full Text] [Related]
19. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
20. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
